跳至主要内容
临床试验/NCT05709873
NCT05709873已完成不适用

Behavioral Treatment of Narcolepsy-Related Nightmares

Northwestern University2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2023年2月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
7
试验地点
2
主要终点
Daily diary

研究概览

简要总结

The goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are:

  • Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares?
  • Does adding targeted dream control (TDC) to IRT make it more effective?

Participants will be randomized to one of two treatment groups and will be asked to:

  • Complete a daily log of sleep symptoms for up to 13 weeks.
  • Attend 7 sessions of treatment.
  • Complete questionnaires before and after treatment.
  • Go to the research lab in Evanston, IL to complete a sleep study during a daytime nap (Chicago area residents only).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (all participants):
  • Diagnosis of narcolepsy
  • Age 18 or older
  • Speak English
  • Live in the United States
  • Receiving standard medical care for narcolepsy
  • Sleep and psychiatric medications stable for at least 3 months
  • Nightmare frequency of ≥3 times per week
  • Nightmare Disorder Index score indicates probable nightmare disorder
  • Inclusion Criteria (Chicago area participants):
  • Able to attend a study appointment in Evanston, IL
  • Able and willing to not take wake-promoting medications on day of lab visit

排除标准

  • History of a neurological disorder that might alter EEG
  • Currently engaged in sleep- or trauma-focused psychotherapy
  • Previous behavioral treatment for nightmares
  • Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
  • Untreated sleep apnea (AHI ≥ 5)

研究组 & 干预措施

Imagery rehearsal therapy and targeted dream control (IRT+TDC)

Experimental

Participants randomized to this group will receive 7 sessions of IRT+TDC.

干预措施: Imagery rehearsal therapy (Behavioral)

Imagery rehearsal therapy and targeted dream control (IRT+TDC)

Experimental

Participants randomized to this group will receive 7 sessions of IRT+TDC.

干预措施: Targeted dream control (Behavioral)

Imagery rehearsal therapy (IRT)

Experimental

Participants randomized to this group will receive 7 sessions of IRT.

干预措施: Imagery rehearsal therapy (Behavioral)

结局指标

主要结局

Daily diary

时间窗: Duration of study (11-13 weeks)

Nightmare severity/frequency

Nightmare Frequency

时间窗: Baseline (assessed daily for 2 or 4 weeks) and posttreatment (assessed daily for 2 weeks beginning in week 9 or 11)

Frequency of nightmares as measured by daily diary

Disturbing Dream and Nightmare Severity Scale

时间窗: Baseline and posttreatment (up to 13 weeks)

Measures nightmare severity. Minimum = 0, maximum = 37. Higher scores represent a worse severity of nightmares.

次要结局

  • Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety Scale(Baseline and posttreatment (up to 13 weeks))
  • Patient Reported Outcomes Measurement Information System (PROMIS) Depression Scale(Baseline and posttreatment (up to 13 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Mundt, PhD

Professor

Northwestern University

研究点 (2)

Loading locations...

相似试验